Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: ...

In the last two decades, mass digitization has dramatically changed the landscape of scholarly research. The ability to ...

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as ...

Many proteins are capable of spontaneously rearranging themselves within cells to form molecular condensates—membraneless ...